MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, onco…
Drug Manufacturers - Specialty & Generic
DE, Darmstadt [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | -9.44 | 1.29 | 1.42 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | -14.97 | 5.06 | 5.95 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 4.93 | 64.39 | 61.36 | |
| Cash | 12.25 | 5.71 | 5.09 | |
| Capex | -156.88 | -2.23 | -0.87 | |
| Free Cash Flow | -90.52 | 0.15 | 1.55 | |
| Revenue | -2.01 | 11.78 | 12.02 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | 5.96 | 0.59 | 0.55 | |
| Operating Margin | 32.05 | 0.21 | 0.16 | |
| ROA | 17.52 | 0.01 | 0.01 | |
| ROE | 12.86 | 0.02 | 0.02 | |
| ROIC | 4.70 | 0.02 | 0.02 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of MKGAF is permitted for members.
5
Growth
The "Growth Entry" for the Focus of MKGAF is permitted for members.
6
Leverage & Liquidity